BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33100273)

  • 41. Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
    Failmezger H; Muralidhar S; Rullan A; de Andrea CE; Sahai E; Yuan Y
    Cancer Res; 2020 Mar; 80(5):1199-1209. PubMed ID: 31874858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
    Wan Q; Tang J; Han Y; Wang D
    Exp Eye Res; 2018 Jan; 166():13-20. PubMed ID: 29031853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
    Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
    Tian M; Yang J; Han J; He J; Liao W
    Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
    Boufaied N; Takhar M; Nash C; Erho N; Bismar TA; Davicioni E; Thomson AA
    J Pathol; 2019 Dec; 249(4):411-424. PubMed ID: 31206668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel four‑snoRNA signature for predicting the survival of patients with uveal melanoma.
    Yi Q; Zou WJ
    Mol Med Rep; 2019 Feb; 19(2):1294-1301. PubMed ID: 30569172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimating Cured Fractions of Uveal Melanoma.
    Singh AD; Zabor EC; Radivoyevitch T
    JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene expression and immune infiltration in melanoma patients with different mutation burden.
    Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z
    BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of prognostic genes in uveal melanoma microenvironment.
    Luo H; Ma C
    PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients.
    He G; Fu S; Li Y; Li T; Mei P; Feng L; Cai L; Cheng Y; Zhou C; Tang Y; Huang W; Liu H; Cen B; Pan M; Gao Y
    Aging (Albany NY); 2020 Nov; 12(21):21544-21558. PubMed ID: 33177245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a prognostic six-immune-gene signature and a nomogram model for uveal melanoma.
    Yang B; Fan Y; Liang R; Wu Y; Gu A
    BMC Ophthalmol; 2023 Jan; 23(1):2. PubMed ID: 36597071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and Validation of Tumor Immunogenicity Based Gene Signature for Skin Cancer Risk Stratification.
    Yavartanoo M; Yi GS
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Machine learning-based integrative analysis of methylome and transcriptome identifies novel prognostic DNA methylation signature in uveal melanoma.
    Hou P; Bao S; Fan D; Yan C; Su J; Qu J; Zhou M
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33367533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.
    Huang L; Chen H; Xu Y; Chen J; Liu Z; Xu Q
    Cancer Med; 2020 Nov; 9(22):8444-8456. PubMed ID: 32931642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
    Liu X; Niu X; Qiu Z
    DNA Cell Biol; 2020 Sep; 39(9):1621-1638. PubMed ID: 32758021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk group.
    Narasimhaiah D; Legrand C; Damotte D; Remark R; Munda M; De Potter P; Coulie PG; Vikkula M; Godfraind C
    Cancer Med; 2019 Jun; 8(6):3036-3046. PubMed ID: 31025552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.